## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -3.7% below STRENGTH zone (4.0-10.0%); PEG 3.57 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($530.41)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Northrop Grumman secures $100 million defense contract for missile systems**
- Source: Investing.com | 20251209T220825 | Bullish | Relevance: 98%
-  Northrop Grumman Systems Corporation has been awarded a $100 million contract by the U.S. Department of War for the development and production of missile weapon systems. This sole-source contract focuses on the Stand-in Attack Weapon and Advanced Anti-Radiation Guided Missile Extended Range systems, with work expected to be completed by December 31, 2034, at its Northridge, California facility. Initial funding of $18,701 for fiscal 2025 research and development was obligated at the time of the award.

**2. Northrop Grumman secures $100 million defense contract for missile systems By Investing.com**
- Source: Investing.com UK | 20251209T222626 | Bullish | Relevance: 98%
-  Northrop Grumman Systems Corporation has been awarded a $100 million contract by the U.S. Department of War for the development and production of missile weapon systems. The contract covers work on Stand-in Attack Weapon and Advanced Anti-Radiation Guided Missile Extended Range systems, including design, development, and testing. This sole-source acquisition is managed by the Air Force Life Cycle Management Center.

**3. Pilotless fighter jets could transform aerial warfare**
- Source: Fox Business | 20251208T203505 | Bullish | Relevance: 98%
-  Northrop Grumman has unveiled "Project Talon," an autonomous combat drone designed to serve as a "loyal wingman" to piloted fighter aircraft. This pilotless jet offers significant cost savings compared to traditional fighter jets, with a projected price range of $15 million to $20 million, and can perform various combat tasks. The ethical consideration of human involvement in weapon firing decisions remains a key aspect for this new technology, which is currently garnering interest from U.S. and international armed forces.

**4. Northrop Grumman Unveils Project Talon Autonomous Aircraft**
- Source: AdvancedManufacturing.org | 20251209T210729 | Bullish | Relevance: 98%
-  Northrop Grumman has unveiled Project Talon, an autonomous aircraft designed to fly alongside crewed fighters, aiming to revolutionize air dominance. Developed in under 24 months, Project Talon emphasizes speed, simplicity, and advanced modular manufacturing to enhance lethality and mission effectiveness through collaborative aircraft technology. This initiative leverages Northrop Grumman's extensive experience in autonomous systems, further advancing its autonomous portfolio alongside projects like Beacon.

**5. State Street Corp Sells 25,962 Shares of Northrop Grumman Corporation $NOC**
- Source: MarketBeat | 20251209T130939 | Neutral | Relevance: 97%
- State Street Corp reduced its stake in Northrop Grumman Corporation (NYSE:NOC) by 0.2% during the second quarter, selling 25,962 shares. Despite this sale, the institutional investor still owned 13,427,807 shares, valued at over $6.7 billion, representing approximately 9.38% of the company. Other institutional investors like Vanguard Group Inc., Soundwatch Capital LLC, and Wellington Management Group LLP increased their holdings in Northrop Grumman during the same period.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.08M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Near-term weakness: 5.7% below SMA50 despite long-term uptrend.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.57 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $78.8B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.57 |
| Forward P/E | 19.1 |
| Current P/E | 21.1 |
| YoY Growth | 10.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -3.7% (minimal 5-day change). Below STRENGTH zone by 7.7pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.02x) but short-term weakness (below SMA20).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.74% (CS: 28) | Weak |
| RSI_14 | 38.6 | Neutral |
| MACD Histogram | -0.09 | Bearish |
| vs SMA20 | 0.984x | Below |
| vs SMA50 | 0.943x | Below |
| vs SMA200 | 1.025x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $550.63
- **Stop Loss:** $530.41 (3.7% risk)
- **Target:** $570.85 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 24
- **Position Value:** $13,215.12
- **Portfolio %:** 13.22%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*